Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Opportunity Score
Confidence: 30%
Complexity: medium
30 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This is an open procedure framework contract for the supply of selective Janus Kinase 1 inhibitor tablets/prolonged release tablets/capsules for inflammatory bowel disease (IBD). The contract is for a single lot with an estimated total value of €5,608,254.60. The buyer is the Department of Contracts in Malta. The deadline for submission is 15 July 2026 at 07:30 (Malta time). Electronic submission is required in English. The notice does not disclose award or selection criteria; only an ESPD (European Single Procurement Document) is referenced. No procurement documents were analyzed beyond the notice.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Must supply pharmaceutical products classified under CPV 33693100
- Electronic submission via eTenders Malta portal
- Tender must be submitted in English
Buyer
Name
Department of Contracts
Location
Floriana, MLT
Website
Buyer profile
Identifier
MT25645419
Lots (1)
Supply of selective JAK1 inhibitor tablets/prolonged release tablets/capsules for IBD.
Procurement Details
Publication
10 Jun 2026
Deadline
15 Jul 2026, 07:30
Procedure
open
Contract
supplies
Language
ENG
Publication #
400302-2026
Classification
Performance: Malta
Documents (2)
Opportunity Score
Confidence: 30%
Complexity: medium
30 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation